{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T12:21:02Z","timestamp":1780316462507,"version":"3.54.1"},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2014,2,26]],"date-time":"2014-02-26T00:00:00Z","timestamp":1393372800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0090023","type":"journal-article","created":{"date-parts":[[2014,2,26]],"date-time":"2014-02-26T22:20:16Z","timestamp":1393453216000},"page":"e90023","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":21,"title":["Triage of HR-HPV Positive Women with Minor Cytological Abnormalities: A Comparison of mRNA Testing, HPV DNA Testing, and Repeat Cytology Using a 4-Year Follow-Up of a Population-Based Study"],"prefix":"10.1371","volume":"9","author":[{"given":"Maria","family":"Persson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Miriam","family":"Elfstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Brismar Wendel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabete","family":"Weiderpass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,2,26]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0301-2115(01)00508-5","article-title":"Time trends in the incidence of cervical and other genital squamous cell carcinomas and adenocarcinomas in Sweden, 1958\u20131996","volume":"101","author":"K Hemminki","year":"2002","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Vaccarella S, Lortet-Tieulent J, Plummer M, Franceschi S, Bray F (2013) Worldwide trends in cervical cancer incidence: Impact of screening against changes in disease risk factors. Eur J Cancer.","DOI":"10.1016\/j.ejca.2013.04.024"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1093\/jnci\/djn131","article-title":"Routine audit of large-scale cervical cancer screening programs","volume":"100","author":"J Cuzick","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1093\/oxfordjournals.aje.a117485","article-title":"Meta-analysis of Pap test accuracy","volume":"141","author":"MT Fahey","year":"1995","journal-title":"Am J Epidemiol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/cncr.10317","article-title":"Use of human papillomavirus DNA testing to compare equivocal cervical cytologic interpretations in the United States, Scandinavia, and the United Kingdom","volume":"96","author":"DR Scott","year":"2002","journal-title":"Cancer"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nrc798","article-title":"Papillomaviruses and cancer: from basic studies to clinical application","volume":"2","author":"H zur Hausen","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1136\/jcp.55.4.244","article-title":"The causal relation between human papillomavirus and cervical cancer","volume":"55","author":"FX Bosch","year":"2002","journal-title":"J Clin Pathol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study","volume":"11","author":"S de Sanjose","year":"2010","journal-title":"Lancet Oncol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1309\/AJCPZ5JY6FCVNMOT","article-title":"High-risk human papillomavirus testing in women with ASC-US cytology: results from the ATHENA HPV study","volume":"135","author":"MH Stoler","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"ref10","unstructured":"Report A (2012) Swedish National Quality Register for Cervical Cancer Prevention."},{"key":"ref11","unstructured":"SFOG (2010) Cervical cancer prevention. Sweden."},{"key":"ref12","doi-asserted-by":"crossref","first-page":"K29","DOI":"10.1016\/j.vaccine.2008.06.019","article-title":"Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries","volume":"26","author":"J Cuzick","year":"2008","journal-title":"Vaccine"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1365-2303.2008.00623.x","article-title":"European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1","volume":"19","author":"J Jordan","year":"2008","journal-title":"Cytopathology"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"F88","DOI":"10.1016\/j.vaccine.2012.06.095","article-title":"Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer","volume":"30","author":"M Arbyn","year":"2012","journal-title":"Vaccine"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/LGT.0b013e318287d329","article-title":"2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors","volume":"17","author":"LS Massad","year":"2013","journal-title":"J Low Genit Tract Dis"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/1096-9071(200010)62:2<251::AID-JMV18>3.0.CO;2-V","article-title":"Ubiquitous presence of E6 and E7 transcripts in human papillomavirus-positive cervical carcinomas regardless of its type","volume":"62","author":"S Nakagawa","year":"2000","journal-title":"J Med Virol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/jmv.20062","article-title":"Human papillomavirus type specific DNA and RNA persistence\u2013implications for cervical disease progression and monitoring","volume":"73","author":"KS Cuschieri","year":"2004","journal-title":"J Med Virol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1158\/1055-9965.EPI-08-0306","article-title":"Human papillomavirus mRNA and p16 detection as biomarkers for the improved diagnosis of cervical neoplasia","volume":"17","author":"K Cuschieri","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/ijc.25726","article-title":"Evaluation of oncogenic human papillomavirus RNA and DNA tests with liquid-based cytology in primary cervical cancer screening: the FASE study","volume":"129","author":"J Monsonego","year":"2011","journal-title":"Int J Cancer"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/S1386-6532(09)70009-5","article-title":"Clinical performance of the APTIMA HPV Assay for the detection of high-risk HPV and high-grade cervical lesions","volume":"45","author":"J Dockter","year":"2009","journal-title":"J Clin Virol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/sj.bjc.6605165","article-title":"Age-specific prevalence of HPV genotypes in cervical cytology samples with equivocal or low-grade lesions","volume":"101","author":"S Brismar-Wendel","year":"2009","journal-title":"Br J Cancer"},{"key":"ref22","first-page":"301","article-title":"Cervical intraepithelial neoplasia","volume":"8","author":"RM Richart","year":"1973","journal-title":"Pathol Annu"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1001\/jama.287.16.2114","article-title":"The 2001 Bethesda System: terminology for reporting results of cervical cytology","volume":"287","author":"D Solomon","year":"2002","journal-title":"JAMA"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"S3\/1","DOI":"10.1016\/j.vaccine.2006.05.115","article-title":"Chapter 1: HPV in the etiology of human cancer","volume":"24","author":"N Munoz","year":"2006","journal-title":"Vaccine"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/S1386-6532(09)70008-3","article-title":"Efficiency of the APTIMA HPV Assay for detection of HPV RNA and DNA targets","volume":"45","author":"D Getman","year":"2009","journal-title":"J Clin Virol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1016\/S1386-6532(09)70007-1","article-title":"Analytical characterization of the APTIMA HPV Assay","volume":"45","author":"J Dockter","year":"2009","journal-title":"J Clin Virol"},{"key":"ref27","first-page":"346","article-title":"High-risk human papillomavirus E6\/E7 mRNA and L1 DNA as markers of residual\/recurrent cervical intraepithelial neoplasia","volume":"28","author":"M Persson","year":"2012","journal-title":"Oncol Rep"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/bjc.2013.22","article-title":"Comparing the performance of six human papillomavirus tests in a screening population","volume":"108","author":"J Cuzick","year":"2013","journal-title":"Br J Cancer"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.5858\/2010-0411-OAR","article-title":"Clinical performance of a human papillomavirus messenger RNA test (Aptima HPV Assay) on residual material from archived 3-year-old PreservCyt samples with low-grade squamous intraepithelial lesion","volume":"135","author":"M Waldstrom","year":"2011","journal-title":"Arch Pathol Lab Med"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/pgp.0b013e31805152ab","article-title":"CIN2 is a much less reproducible and less valid diagnosis than CIN3: results from a histological review of population-based cervical samples","volume":"26","author":"JD Carreon","year":"2007","journal-title":"Int J Gynecol Pathol"},{"key":"ref31","unstructured":"International Agency for Research on Cancer (2012) IARC Monographs on the evaluation of carcinogenic risks to humans, vol 100B, HPV. Lyon, France: International Agency for Research on Cancer."},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1128\/JCM.01674-10","article-title":"Performance of the Aptima high-risk human papillomavirus mRNA assay in a referral population in comparison with Hybrid Capture 2 and cytology","volume":"49","author":"A Clad","year":"2011","journal-title":"J Clin Microbiol"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Arbyn M, Roelens J, Cuschieri K, Cuzick J, Szarewski A, <etal>et al<\/etal>.. (2012) The APTIMA HPV assay versus the hybrid capture 2 test in triage of women with ASC-US or LSIL cervical cytology: A meta-analysis of the diagnostic accuracy. Int J Cancer.","DOI":"10.1002\/ijc.27636"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ygyno.2011.07.024","article-title":"Comparison of different commercial methods for HPV detection in follow-up cytology after ASCUS\/LSIL, prediction of CIN2\u20133 in follow up biopsies and spontaneous regression of CIN2\u20133","volume":"123","author":"IT Ovestad","year":"2011","journal-title":"Gynecol Oncol"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Mesher D, Szarewski A, Cadman L, Austin J, Ashdown-Barr L, <etal>et al<\/etal>.. (2013) Comparison of human papillomavirus testing strategies for triage of women referred with low-grade cytological abnormalities. Eur J Cancer.","DOI":"10.1016\/j.ejca.2013.01.018"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1128\/JCM.06587-11","article-title":"High-risk human papillomavirus (hrHPV) E6\/E7 mRNA testing by PreTect HPV-Proofer for detection of cervical high-grade intraepithelial neoplasia and cancer among hrHPV DNA-positive women with normal cytology","volume":"50","author":"DC Rijkaart","year":"2012","journal-title":"Journal of Clinical Microbiology"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0090023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T00:42:49Z","timestamp":1565224969000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0090023"}},"subtitle":[],"editor":[{"given":"Anthony WI.","family":"Lo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,2,26]]},"references-count":36,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,2,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0090023","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,26]]}}}